Experience in Using Antiviral Agents for the Treatment of Novel Coronavirus Infection (COVID-19) in Kyrgyzstan
The national clinical guidelines for the treatment of novel coronavirus infection (COVID-19) are the main source of information and the reference point for clinical decision-making by healthcare professionals in the Kyrgyz Republic. The recommendations presented in these documents are largely based...
Saved in:
Main Authors: | A. A. Zurdinova (Author), A. Z. Kutmanova (Author) |
---|---|
Format: | Book |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structure of Adverse Events Following Immunisation against Coronavirus Infection (COVID-19) in the Kyrgyz Republic
by: A. A. Zurdinova, et al.
Published: (2022) -
Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
by: Shahamah Jomah, et al.
Published: (2020) -
Experience of Using Remdesivir in Patients with Novel Coronavirus Infection
by: V. I. Petrov, et al.
Published: (2022) -
The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19
by: Jin A. Shin, et al.
Published: (2021) -
The new oral antiviral agents for COVID-19
by: S.L. Seneviratne, et al.
Published: (2022)